Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | HLA-G |
| Upstream (Parents) |
|---|
| (<<) DEAF1 → HLA-G |
| (<<) EIF6 → HLA-G |
| (<<) GPX1 → HLA-G |
| (<<) HLA-A → HLA-G |
| (<<) HSPA8 → HLA-G |
| (<<) PGK1 → HLA-G |
| (<<) PKM2 → HLA-G |
| (<<) RBM7 → HLA-G |
| (<<) RHOC → HLA-G |
| (<<) SH3GLB1 → HLA-G |
| (<<) STAT3 → HLA-G |
| (<<) UBE2D2 → HLA-G |
| Downstream (Children) |
|---|
| HLA-G → ADORA2B (>>) |
| HLA-G → ARAF (>>) |
| HLA-G → CD4 (>>) |
| HLA-G → CORO1A (>>) |
| HLA-G → CSTB (>>) |
| HLA-G → DHCR7 (>>) |
| HLA-G → FGFR3 (>>) |
| HLA-G → GLRX (>>) |
| HLA-G → GNG12 (>>) |
| HLA-G → HLA-F (>>) |
| HLA-G → HRAS (>>) |
| HLA-G → IFITM3 (>>) |
| HLA-G → ISG20 (>>) |
| HLA-G → ITGB6 (>>) |
| HLA-G → LCP1 (>>) |
| HLA-G → ME1 (>>) |
| HLA-G → NFKB1 (>>) |
| HLA-G → PYGL (>>) |
| HLA-G → RASSF1 (>>) |
| HLA-G → RDX (>>) |
| HLA-G → SDK2 (>>) |
| HLA-G → SHC2 (>>) |
| HLA-G → STK16 (>>) |
| HLA-G → TIMP1 (>>) |
| HLA-G → TINF2 (>>) |
| HLA-G → TSC22D1 (>>) |
| HLA-G → TUBA4A (>>) |
| HLA-G → UBE2L6 (>>) |
| HLA-G → ZNF205 (>>) |
